Summary
Boston Scientific Corporation (BSX) has filed an 8-K report detailing updates to its executive compensation programs for 2021. The company's Board of Directors has approved the 2021 Annual Bonus Plan, which ties cash incentives for eligible salaried personnel, including named executive officers, to corporate-level performance metrics. These metrics include adjusted earnings per share, global sales on a constant currency basis, human capital metrics, and quality goals. The plan allows for a maximum bonus pool of 150% of the aggregate annual target, with the Board retaining discretion to adjust bonuses based on quality objectives and performance. Furthermore, BSX has established two new performance share programs for 2021: the Total Shareholder Return Performance Share Program (2021 TSR PSP) and the Free Cash Flow Performance Share Program (2021 FCF PSP). The 2021 TSR PSP will award performance shares based on BSX's total shareholder return relative to the S&P 500 Healthcare Index over a three-year period, with potential awards ranging from 0% to 200% of target. The 2021 FCF PSP incentivizes executive officers based on the company's free cash flow performance against its 2021 financial plan, with potential awards from 0% to 150% of target over a one-year performance period. Both performance share programs are designed to align executive interests with shareholder value and are subject to a recoupment policy, including provisions for misconduct, financial restatements, and Dodd-Frank Act clawbacks.
Key Highlights
- 1Boston Scientific has approved its 2021 Annual Bonus Plan, linking executive and employee incentives to corporate performance metrics like adjusted EPS, global sales, and quality goals.
- 2The 2021 Annual Bonus Plan has a maximum payout of 150% of the aggregate annual target, with Board discretion to modify based on company performance.
- 3Two new performance share programs, the 2021 Total Shareholder Return (TSR) Performance Share Program and the 2021 Free Cash Flow (FCF) Performance Share Program, have been approved for 2021.
- 4The 2021 TSR PSP will measure BSX's TSR against the S&P 500 Healthcare Index over three years, with awards ranging from 0% to 200% of target.
- 5The 2021 FCF PSP will reward performance based on the company's free cash flow achievement against its 2021 financial plan, with awards ranging from 0% to 150% of target.
- 6Both performance share programs and the annual bonus plan include provisions for recoupment of awards in cases of executive misconduct, financial restatements, or required clawbacks under law (e.g., Dodd-Frank Act).
- 7These new compensation plans are designed to align executive compensation with shareholder interests and reinforce a pay-for-performance philosophy.